Park J H, Chen K W, Lee S K. "Method for the Synthesis of 17-Methyl-5α-androst-2-eno[2,3-d]isoxazol-17β-ol" [P]. US Patent, US 9391538 B2, 2015-08-08.
发明人陈志强,唐晓军,胡光. "A Process for Preparing High-Purity 17-Methyl-5α-androst-2-eno[2,3-d]isoxazol-17β-ol" [P]. 中国发明专利, 专利号 CN 108601685 B, 授权公告日 2021-11-13.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Chemosphere, 2012, 451, (9), 1889-1910.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2020, 2468, 5127-5131.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of 17-Methyl-5α-androst-2-eno[2,3-d]isoxazol-17β-ol Using HRMS and NMR". Biomed. Chromatogr., 2012, 1513, 8138-8159.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Molecules, 2016, 2408, (3), 4591-4618.